Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Cardona

Showing results (191-200 of 333) with videos related to

Pageof 34
Sort By:
Revista Espanola De Enfermedades Digestivas|October 1, 1992
[Cholecystectomy via laparoscopy: one and a half year's experience]J Foncillas Corvinos, V Canela Mercader, R Antón Belle, et al.
Intensive Care Medicine Experimental|July 1, 2026
Improving mortality prediction in critically ill cancer patients with a multidimensional machine learning modelVíctor H Nieto, Adriana C Aya, Andrés F Cardona, et al.
Future Oncology (London, England)|September 28, 2020
Brigatinib in <i>ALK</i>-positive non-small cell lung cancer: real-world data in the Latin American population (Bri-world extend CLICaP)David Heredia, Feliciano Barrón, Andrés F Cardona, et al.
Translational Lung Cancer Research|November 17, 2022
The efficacy and safety of immune checkpoint inhibitors combined with chemotherapy or anti-angiogenic therapy as a second-line or later treatment option for advanced non-small cell lung cancer: a retrospective comparative cohort studyBolin Chen, Jingyi Wang, Xingxiang Pu, et al.
Clinical Lung Cancer|June 10, 2025
Chemotherapy Plus Anti-PD-1 or Anti-PD-L1 in Advanced PD-L1-Negative Squamous Cell Lung Carcinoma: A Systematic Review and Meta-AnalysisNicolas Peruzzo, Gabriel Lenz, Ted Akhiwu, et al.
Lung Cancer (Amsterdam, Netherlands)|February 9, 2021
Risk of development of brain metastases according to the IASLC/ATS/ERS lung adenocarcinoma classification in locally advanced and metastatic diseaseOscar Arrieta, Alejandro Avilés Salas, Andrés F Cardona, et al.
Oncotarget|August 11, 2018
Targeted next generation sequencing identified a high frequency genetic mutated profile in wood smoke exposure-related lung adenocarcinoma patientsGiovanny Soca-Chafre, Norma Hernández-Pedro, Alejandro Aviles-Salas, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|July 25, 2023
Impact of KRAS<sup>G12D</sup> subtype and concurrent pathogenic mutations on advanced non-small cell lung cancer outcomesEnrique Caballé-Perez, Norma Hernández-Pedro, Maritza Ramos-Ramírez, et al.
Translational Lung Cancer Research|April 23, 2021
Isochorismatase domain-containing protein 1 (ISOC1) participates in DNA damage repair and inflammation-related pathways to promote lung cancer developmentJinghan Shi, Fujun Yang, Nanfeng Zhou, et al.
Vaccine|February 24, 2023
Safety and immunogenicity of a 20-valent pneumococcal conjugate vaccine coadministered with quadrivalent influenza vaccine: A phase 3 randomized trialKevin Cannon, Jose F Cardona, Kari Yacisin, et al.
Pageof 34

Showing results (191-200 of 333) with videos related to

Sort By:
Pageof 34
Revista Espanola De Enfermedades Digestivas|October 1, 1992
[Cholecystectomy via laparoscopy: one and a half year's experience]J Foncillas Corvinos, V Canela Mercader, R Antón Belle, et al.
Intensive Care Medicine Experimental|July 1, 2026
Improving mortality prediction in critically ill cancer patients with a multidimensional machine learning modelVíctor H Nieto, Adriana C Aya, Andrés F Cardona, et al.
Future Oncology (London, England)|September 28, 2020
Brigatinib in <i>ALK</i>-positive non-small cell lung cancer: real-world data in the Latin American population (Bri-world extend CLICaP)David Heredia, Feliciano Barrón, Andrés F Cardona, et al.
Translational Lung Cancer Research|November 17, 2022
The efficacy and safety of immune checkpoint inhibitors combined with chemotherapy or anti-angiogenic therapy as a second-line or later treatment option for advanced non-small cell lung cancer: a retrospective comparative cohort studyBolin Chen, Jingyi Wang, Xingxiang Pu, et al.
Clinical Lung Cancer|June 10, 2025
Chemotherapy Plus Anti-PD-1 or Anti-PD-L1 in Advanced PD-L1-Negative Squamous Cell Lung Carcinoma: A Systematic Review and Meta-AnalysisNicolas Peruzzo, Gabriel Lenz, Ted Akhiwu, et al.
Lung Cancer (Amsterdam, Netherlands)|February 9, 2021
Risk of development of brain metastases according to the IASLC/ATS/ERS lung adenocarcinoma classification in locally advanced and metastatic diseaseOscar Arrieta, Alejandro Avilés Salas, Andrés F Cardona, et al.
Oncotarget|August 11, 2018
Targeted next generation sequencing identified a high frequency genetic mutated profile in wood smoke exposure-related lung adenocarcinoma patientsGiovanny Soca-Chafre, Norma Hernández-Pedro, Alejandro Aviles-Salas, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|July 25, 2023
Impact of KRAS<sup>G12D</sup> subtype and concurrent pathogenic mutations on advanced non-small cell lung cancer outcomesEnrique Caballé-Perez, Norma Hernández-Pedro, Maritza Ramos-Ramírez, et al.
Translational Lung Cancer Research|April 23, 2021
Isochorismatase domain-containing protein 1 (ISOC1) participates in DNA damage repair and inflammation-related pathways to promote lung cancer developmentJinghan Shi, Fujun Yang, Nanfeng Zhou, et al.
Vaccine|February 24, 2023
Safety and immunogenicity of a 20-valent pneumococcal conjugate vaccine coadministered with quadrivalent influenza vaccine: A phase 3 randomized trialKevin Cannon, Jose F Cardona, Kari Yacisin, et al.
Pageof 34